7 Allergy FDA News and 2 Interview Spotlights from First Half of 2025

In this recap of 7 FDA updates and 2 interview spotlights in allergy from the first half of 2025, we review important advances in allergy care. At the 2025 American Academy of Allergy, Asthma, & Immunology (AAAAI) in San Diego, oral immunotherapy showed promise for peanut allergy in young children, and tezepelumab improved nasal polyp severity in CRSwNP.